ACP
Acuta Capital Partners’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-92,346
| Closed | -$2.98M | – | 36 |
|
|
2024
Q1 | $2.98M | Sell |
92,346
-27,143
| -23% | -$877K | 1.94% | 20 |
|
|
2023
Q4 | $5.03M | Sell |
119,489
-9,511
| -7% | -$401K | 2.83% | 16 |
|
|
2023
Q3 | $4.95M | Sell |
129,000
-12,755
| -9% | -$490K | 3.32% | 12 |
|
|
2023
Q2 | $2.69M | Buy |
+141,755
| New | +$2.69M | 1.82% | 20 |
|
|
2021
Q1 | – | Sell |
-283,500
| Closed | -$13.1M | – | 52 |
|
|
2020
Q4 | $13.1M | Buy |
283,500
+33,500
| +13% | +$1.55M | 3.56% | 9 |
|
|
2020
Q3 | $8.8M | Sell |
250,000
-100,000
| -29% | -$3.52M | 2.39% | 14 |
|
|
2020
Q2 | $8.52M | Buy |
+350,000
| New | +$8.52M | 2.46% | 15 |
|